# FDA 483 - Jason A. Ohayon, MD - November 12, 2025

Source: https://www.globalkeysolutions.net/records/483/jason-a-ohayon-md/a382b0fc-7426-4b33-bb21-94f5f4f74528

> FDA 483 for Jason A. Ohayon, MD on November 12, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jason A. Ohayon, MD
- Inspection Date: 2025-11-12
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Jason A. Ohayon, MD, a clinical investigator in Hamilton, ON, revealed a failure to conduct a clinical study according to good clinical practices. The site did not follow the investigational plan and maintain adequate case histories for pharmacokinetic sample processing and shipment. This included a lack of records for sample handling and improper co-shipment of primary and backup samples.

## Related Documents

- [483 - 2025-11-12](https://www.globalkeysolutions.net/records/483/jason-a-ohayon-md/b957d273-b076-4eca-8c63-52bf50f2e3b4)

## Related Officers

- [Bioresearch Monitoring Foreign Inspection Cadre Member](https://www.globalkeysolutions.net/people/richard-w-berning/4637e321-8803-4fcf-911f-bbc810c3487d)

Company: https://www.globalkeysolutions.net/companies/jason-a-ohayon-md/28d7a93a-875b-429e-a58f-46af4198cb2d

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8